Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that...
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that...
COPENHAGEN - A Danish study released on Wednesday found face masks provide the wearer with only limited protection against COVID-19 infection, but said...
Paris: More than four billion people could be overweight by 2050, with 1.5 billion of them obese, if the current global dietary trend...
Pfizer Inc. said a final analysis of clinical-trial data showed its Covid-19 vaccine was 95% effective, paving the way for the company to...
Washington - In a grim milestone, the overall number of global coronavirus cases has surpassed the 55 million mark on Tuesday, while the...
The World Health Organization welcomed news that Moderna Inc's COVID-19 vaccine candidate showed 94.5% efficacy but said "many questions" remained and it was...
TORONTO: Early in the pandemic, a few cities and countries around the world began testing sewage for evidence of the coronavirus, hoping to...
LONDON/GENEVA: A facility set up by the World Health Organization (WHO) and the GAVI vaccine group has exceeded an interim target of raising...
Top Democrats in the U.S. Congress on Thursday urged renewed negotiations over a multitrillion-dollar coronavirus aid proposal, but the top Republican immediately rejected...
Shortages of flu shots this year are not related to drugmakers ramping up production of potential COVID-19 vaccines, the head of vaccines at...
NEW YORK: Work to distribute the experimental COVID-19 vaccine developed by Pfizer Inc and BioNTech SE is gearing up after the companies announced...
The Covid-19 vaccine being developed by Pfizer Inc. and BioNTech SE prevented more than 90% of infections in a study of tens of...
Global coronavirus infections exceeded 50 million on Sunday, according to a Reuters tally, with a second wave of the virus in the past...
LONDON: Severe disruptions caused by the COVID-19 pandemic to immunisation campaigns against measles and polio are putting millions of vulnerable children at risk...
AstraZeneca will start discussing emergency approval of its experimental COVID-19 vaccine with U.S. regulators once it has good trial data from Britain, South...
AstraZeneca, the British drugmaker working on one of the world's leading COVID-19 vaccine candidates, beat third-quarter sales estimates on Thursday and reiterated it...
Newly introduced restrictions could slow economic recovery or even lead to a contraction in Spain and other European countries in the fourth quarter,...
LONDON: The COVID-19 vaccine developed by the University of Oxford could present late-stage trial results before the year end but it is unclear...
